Evan Crain, MD
Sports Medicine · Newark, DENPI 1598745408
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $878 of the $1,133 with a category attached, or 77.5%. 9 manufacturers reported payments, led by Zimmer Biomet at 43.9% of the total. 2025 is the largest year on record at $441, 2.9 times the $152 reported in 2019.
Across 21 payments — averaging $53.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$497
- Smith+Nephew$231
- Medacta USA, Inc.$110
- AstraZeneca$100
- Davol Inc.$93
- Liberty Surgical Inc.$53
- plus $49 from 3 others
What the payments were for
- Travel & lodging$25522%
- Food & beverage$87878%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 6 | $497 |
| Smith+Nephew | 8 | $231 |
| Medacta USA, Inc. | 1 | $110 |
| AstraZeneca | 1 | $100 |
| Davol Inc. | 1 | $93 |
| Liberty Surgical Inc. | 1 | $53 |
| Eclipse Technology Solutions Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $15 |
| Synergy Orthopedics, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EFFICIENCY$110
- FARXIGA$100
How this compares
Too few sports medicine providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 254 | $1,682 |
| Amoxicillin | 67 | $151 |
| Methylprednisolone | 18 | $104 |
| Clindamycin Hcl | 21 | $39 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Newark
- Michael AxeNewark$120K
- Joseph StraightNewark$6K
- Bradley BleyNewark$3K
- Craig SternbergNewark$131
- Geoffrey GustavsenNewark$16
- Matthew VoltzWilmington$831
- Arnold GlassmanWilmington$485
- Barry BakstWilmington$200
- Terrence TsuiDover$71
- Claire SheltonWilmington$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.